Skip to content

In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints

In Vitro Exposure by VR to Enhance Return to Work After Sick Leave Due to Mental Health Related Complaints

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06888999
Enrollment
118
Registered
2025-03-21
Start date
2025-11-17
Completion date
2027-03-31
Last updated
2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occupational Stress, Return to Work, Self-Efficacy

Keywords

virtual reality, return to work, pilot randomized controlled trial, cabin crew, stress, return to work self-efficacy, job anxiety, usability, return to work attitude

Brief summary

The goal of this pilot randomised controlled trial is to investigate whether in vitro exposure by VR enhances return to work (RTW) in flight cabin crew on sick leave with mental health related complaints. The main research questions are: 1. Does VR enhances time to RTW? 2. Does VR increase self-efficacy and positive cognitions regarding RTW, and decrease job anxiety? Researchers will compare a control group receiving care as usual as provided by the occupational physician and a psychologist to an intervention group receiving care as usual plus (al least) one session with VR-glasses in which participants are virtually exposed to their workplace.

Detailed description

This study evaluates the effectiveness of in vitro exposure to the workplace by means of VR to decrease time to RTW of sick-listed flight cabin crew with mental health related complaints compared to usual care. The study design is a pilot randomized controlled trial, including an intervention and control group. Sick-listed workers in the control group receive care as usual from the occupational physician and a psychologist. Sick-listed workers in the intervention group receive care as usual from the occupational physician and a psychologist and participate in a VR-session. During the VR-session, guided by the psychologist, participants are virtually exposed to their workplace. Data on the primary outcome of RTW is collected based on the register data from the occupational health service (6 and 12 months after baseline). Data on secondary outcomes (self-efficacy, cognitions regarding RTW and job anxiety) is collected with baseline and follow-up questionnaires (4 months after baseline).

Interventions

OTHERIn vitro exposure to workplace by VR plus care as usual

During the VR-session, guided by the psychologist, participants are virtually exposed to their workplace using VR glasses. Based on the experience of the participants during the vitual visit to their workplace, the psychologist can adjust the therapy. In addition care as usual is provided (see description active comparator).

OTHERCare as usual: Guidance from occupational physician and psychologist focused on returning to work

Guidance by the occupational physician and a psychologist from a psychologist practice specialized in counseling cabin crew and guiding them with returning to work.

Sponsors

KLM Royal Dutch Airlines
CollaboratorUNKNOWN
KLM Health Services
CollaboratorUNKNOWN
Villa Uitzicht
CollaboratorUNKNOWN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Due to the intervention, it is not possible to blind researchers, case provides, investigators and participants.

Intervention model description

Randomized controlled trial comparing an intervention group with a care as usual group. Randomization is carried out at the individual level.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

\- sick listed cabin crew with mental health related complaints that are referred by the occupational physician to a specific psychotherapist practice

Exclusion criteria

* epilepsy * vestibular disorder * no signed informed consent

Design outcomes

Primary

MeasureTime frameDescription
Time to RTW6 months and 12 months after baselineTime between start of sickness absence until participant is considered 'fit to fly' by the occupational physician, measured by register data from the occupational health service.

Secondary

MeasureTime frameDescription
Stress-related complaintsBaseline and 4-months follow-upStress-related complaints (e.g., type of disease, severity of symptoms) by means of Perceived Stress Scale (PSS-10). The PSS-10 consists of 10 items rated on a 5-point Likert scale, ranging from 0 (never) to 4 (very often). A high score means more stress-related complaints
Self-efficacy regarding return to workBaseline and 4-months follow-upSelf-efficacy regarding return to work measured by Return-to-Work Self-Efficacy scale (RTW-SE). The RTW-SE contains of 11 items. The items are rated on a five point scale The response categories vary from 1 (totally disagree) to 6 (totally agree). A high score means more return to work self-efficacy
Attitude regarding return to workBaseline and 4-months follow-upScale on attitude regarding return to work. Attitude regarding return to work is measured with a 8-item scale measuring the attitude towards working again. The items are rated on a 4-point scale ranging from 1 (disagree very strongly) to 4 (agree very strongly). A higher score means a more positive attitude towards return to work.
Job anxietyBaseline and 4-months follow-upAnxiety related to the job measured by the Job Anxiety Scale. The items are rated on a 5-point Likert scale, ranging from of 0 (no agreement) to 4 (full agreement). A higher score means more job anxiety.

Countries

Netherlands

Contacts

Primary ContactMaartje C. Bakhuys Roozeboom, PhD
m.c.bakhuysroozeboom@amsterdamumc.nl0031619352778

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026